FOXM1 Signaling in Ovarian Cancer Cells
Author Information
Author(s): Lok Gabriel T. M., Chan David W., Liu Vincent W. S., Hui Winnie W. Y., Leung Thomas H. Y., Yao K. M., Ngan Hextan Y. S.
Primary Institution: The University of Hong Kong
Hypothesis
The study investigates the role of ERK/FOXM1 signaling in the metastatic potential of ovarian cancer cells.
Conclusion
The study suggests that over-expression of FOXM1, driven by active ERK signaling, contributes to the metastatic capabilities of ovarian cancer cells.
Supporting Evidence
- FOXM1 expression was significantly correlated with high-grade ovarian tumors.
- High levels of phospho-ERK were found in aggressive ovarian cancer cases.
- FOXM1 inhibitors reduced cell migration and invasion in ovarian cancer cells.
Takeaway
FOXM1 is a protein that helps cancer cells move and spread, and blocking it could help treat ovarian cancer.
Methodology
The study used immunohistochemical analysis, immunoblotting, and semi-quantitative RT-PCR to assess FOXM1 and pERK expression in ovarian cancer samples and cell lines.
Limitations
The sample size for some analyses was limited, which may affect the generalizability of the findings.
Participant Demographics
The study included 97 ovarian tissue samples, with a mix of normal, benign, borderline, and malignant tumors.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website